» Articles » PMID: 29256360

Roles of Glutamate and Glutamine Transport in Ammonia Neurotoxicity: State of the Art and Question Marks

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Excessive accumulation of ammonia in the brain is a causative factor of an array of neurological manifestations of hyperammonemic encephalopathies ("hyperammonemias", HA) among which hepatic encephalopathy (HE) is a major epidemiologic and therapeutic challenge. While ammonia neurotoxicity is symptomatically and mechanistically very complex, there is a consensus with regard to the leading role in its pathogenesis of: i) astrocytes being the primary cellular target of ammonia toxicity; ii) alterations of glutamate (Glu)-dependent neurotransmission (over-excitation followed by inhibition of glutamatergic tone) being the cornerstone of its neurophysiological manifestations; and iii) brain edema, an often lethal consequence of astrocytic swelling, being among other factors caused by the retention of glutamine (Gln) in these cells.

Objective: This article critically evaluates the present literature attempting to relate manifestations of HA to changes in astrocytic Glu and Gln transport as observed in different in vivo and in vitro HA and/or HE models. Emphasis is put on two disproportions in the state of the art: i) the paucity of available data regarding ammonia-dependent changes in Glu transport activity vs the relative abundance of information on the expression of astrocytic Glu transporters (GLT-1/EAAT2 and GLAST/EAAT1); ii) the just emerging still not very conclusive knowledge on the response of astrocytic Gln transporters SN1 and SN2.

Conclusion: The review on the above issues is complemented by own recent data which fill some of the many gaps in the knowledge. A brief account is included on the roles of heteromeric cell membrane Glu/arginine (Arg) exchanger y+LAT2 and on the mitochondrial Gln transport.

Citing Articles

Prognostic value of serum ammonia in critical patients with non-hepatic disease: A prospective, observational, multicenter study.

Li Y, Yao Z, Li Y, Yang Z, Li M, Chen Z J Transl Int Med. 2023; 11(4):401-409.

PMID: 38130646 PMC: 10732347. DOI: 10.2478/jtim-2022-0021.


Comparison of Psychiatric and Clinical Profiles Between People Who Use Synthetic Cathinones and Methamphetamine: A Matched Case-Control Study.

Lin C, Chen J, Chan C J Clin Psychopharmacol. 2023; 43(2):122-130.

PMID: 36706307 PMC: 9988231. DOI: 10.1097/JCP.0000000000001649.


Decoding the contributions of gut microbiota and cerebral metabolism in acute liver injury mice with and without cognitive dysfunction.

Sun T, Du H, Li Z, Xiong J, Liu Y, Li Y CNS Neurosci Ther. 2022; 29 Suppl 1:31-42.

PMID: 36585803 PMC: 10314109. DOI: 10.1111/cns.14069.


Inhibition of Glutamate Release, but Not of Glutamine Recycling to Glutamate, Is Involved in Delaying the Onset of Initial Lithium-Pilocarpine-Induced Seizures in Young Rats by a Non-Convulsive MSO Dose.

Pawlik M, Aldana B, Belfiori-Carrasco L, Obara-Michlewska M, Popek M, Czarnecka A Int J Mol Sci. 2021; 22(20).

PMID: 34681786 PMC: 8536987. DOI: 10.3390/ijms222011127.


Deciphering the effects of PYCR1 on cell function and its associated mechanism in hepatocellular carcinoma.

Xu Y, Zuo W, Wang X, Zhang Q, Gan X, Tan N Int J Biol Sci. 2021; 17(9):2223-2239.

PMID: 34239351 PMC: 8241733. DOI: 10.7150/ijbs.58026.